After years of debilitating bouts of fatigue, Beth VanOrden finally thought she had an answer to her problems in 2016 when ...
Investors in Padlock Therapeutics have accused Bristol Myers Squibb of reneging on payments of up to $450 million negotiated ...
Several rare immune disorders are caused by mutations in the patient's DNA. In a new study published in the Journal of ...
Nektar Therapeutics (NKTR) has received a new Buy rating, initiated by H.C. Wainwright analyst, Arthur He CFA.Pick the best stocks and maximize ...
In Philadelphia’s Norris Square neighborhood, Shannon Turner, a celebrated singer, vocal coach, and founder of the band ...
Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria.
Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria. When such ...
Cyrus Biotechnology announces potent in vivo redosability of an engineered IdeS protease for IgG-driven autoimmune disease.
Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they were foreign invaders. This widespread category of illnesses, such as ...
By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.
In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader who found that an antibiotic helped treat their rosacea.
In an interview with Ophthalmology Times, Alon Kahana, MD, PhD, discusses interleukin-6 and its role in autoimmune diseases, particularly thyroid eye disease, noting that a promising alternative under ...